OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

INTRODUCTION: To evaluate the efficacy and safety of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity (NDO) in subpopulations of etiology (multiple sclerosis [MS] or spinal cord injury [SCI]) and concomitant anticholinergics (use/non-use). METHODS: Data were pooled from two d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ginsberg, David, Cruz, Francisco, Herschorn, Sender, Gousse, Angelo, Keppenne, Véronique, Aliotta, Philip, Sievert, Karl-Dietrich, Brin, Mitchell F., Jenkins, Brenda, Thompson, Catherine, Lam, Wayne, Heesakkers, John, Haag-Molkenteller, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824824/
https://www.ncbi.nlm.nih.gov/pubmed/24072665
http://dx.doi.org/10.1007/s12325-013-0054-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824824/
https://www.ncbi.nlm.nih.gov/pubmed/24072665
http://dx.doi.org/10.1007/s12325-013-0054-z

Ejemplares similares